160 related articles for article (PubMed ID: 23623283)
1. Tremor as dose dependent side-effect of azathioprine in remission patient with ileal Crohn's disease.
Karaahmet F; Akinci H; Ayte R; Hamamci M; Coskun Y; Yuksel I
J Crohns Colitis; 2013 Oct; 7(9):e404. PubMed ID: 23623283
[No Abstract] [Full Text] [Related]
2. Azathioprine-Induced Tremor: A Rare, Dose-Dependent Side Effect of Azathioprine in a Patient With Active Crohn Disease.
Fasoulas K; Kafalis N; Soufleris K
Inflamm Bowel Dis; 2020 Jun; 26(7):e72. PubMed ID: 32444877
[No Abstract] [Full Text] [Related]
3. Spot diagnosis: eruptive melanocytic naevi during azathioprine therapy in Crohn's disease.
Wonders J; De Boer NK; Van Weyenberg SJ
J Crohns Colitis; 2012 Jun; 6(5):636. PubMed ID: 22402255
[No Abstract] [Full Text] [Related]
4. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment.
Kilincalp S; Akıncı H; Hamamci M; Coşkun Y; Yüksel I
J Crohns Colitis; 2014 Jun; 8(6):558-9. PubMed ID: 24291020
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
[TBL] [Abstract][Full Text] [Related]
7. [Bacillus cereus bacteremia in Crohn's disease with multiple ileal stricture on maintenance azathioprine therapy].
Hizawa K; Nagata Y; Taniguchi M; Nakamori M; Matsumoto T; Iida M
Nihon Shokakibyo Gakkai Zasshi; 2009 Jan; 106(1):56-60. PubMed ID: 19122422
[TBL] [Abstract][Full Text] [Related]
8. [Azathioprine treatment of Crohn disease].
Thomsen MK; Vilien M; Gerner CU
Ugeskr Laeger; 2000 Jan; 162(3):323-6. PubMed ID: 10680466
[TBL] [Abstract][Full Text] [Related]
9. Initiating azathioprine for Crohn's disease.
Levesque BG; Loftus EV
Clin Gastroenterol Hepatol; 2012 May; 10(5):460-5. PubMed ID: 22330233
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.
Viazis N; Koukouratos T; Anastasiou J; Giakoumis M; Triantos C; Tsolias C; Theocharis G; Karamanolis DG
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):436-41. PubMed ID: 25874518
[TBL] [Abstract][Full Text] [Related]
11. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
[TBL] [Abstract][Full Text] [Related]
13. Steroids may prevent leukopenia, interfering with response to IV azathioprine in treatment of Crohn's disease.
Korelitz BI
Gastroenterology; 2000 Jun; 118(6):1281-2. PubMed ID: 10866522
[No Abstract] [Full Text] [Related]
14. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
15. Three hospital admissions in 9 days to diagnose azathioprine hypersensitivity in a patient with Crohn's disease.
Mookherjee S; Narayanan M; Uchiyama T; Wentworth KL
Am J Ther; 2015; 22(2):e28-32. PubMed ID: 23782763
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature.
Vilas-Boas F; Magro F; Balhau R; Lopes JM; Beça F; Eloy C; Lopes S; Macedo G
J Crohns Colitis; 2012 Aug; 6(7):792-5. PubMed ID: 22464812
[TBL] [Abstract][Full Text] [Related]
17. Splenic littoral cell hemangioendothelioma in a patient with Crohn's disease previously treated with immunomodulators and anti-TNF agents: a rare tumor linked to deep immunosuppression.
Cappello M; Bravatà I; Cocorullo G; Cacciatore M; Florena AM
Am J Gastroenterol; 2011 Oct; 106(10):1863-5. PubMed ID: 21979217
[No Abstract] [Full Text] [Related]
18. Azathioprine dose escalation in inflammatory bowel disease.
Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
[TBL] [Abstract][Full Text] [Related]
19. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ
Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.
Lewis JD; Schwartz JS; Lichtenstein GR
Gastroenterology; 2000 Jun; 118(6):1018-24. PubMed ID: 10833475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
